References
- 1. Kwong TC. Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit 2002;24:144-9. PMID: 11805735
- 2. Macllwain C. Study proves Iraq used nerve gas. Nature 1993;363:3. doi: 10.1038/363003b0
- 3. Nagao M, Takatori T, Matsuda Y, Nakajima M, Iwase H, Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol 1997;144:198-203. PMID: 9169085
- 4. Gunnell D, Eddleston M, Phillips MR, Konradsen F. The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health 2007;7:357. doi: 10.1186/1471-2458-7-357
- 5. Lotti M. Clinical toxicology of anticholinesterase agents in humans. In: Krieger R, editor. Handbook of pesticide toxicology. San Diego: Academic Press; 2001. p. 1043-85.
- 6. Somani SM, Husain K. Low-level nerve agent toxicity under normal and stressful conditions. In: Somani SM, Romano Jr. JA, editors. Chemical warfare agents: toxicity at low levels. Boca Raton (FL): CRS Press LLC; 2001. p. 83-120.
- 7. Antonijević B, Stojiljković MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 2007;5:71-82. doi: 10.3121/cmr.2007.701
- 8. Kuča K, Musilek K, Jun D, Bajgar J, Kassa J. Novel oximes. In: Gupta RC, editor. Handbook of toxicology of chemical warfare agents. London: Elsevier; 2009. p. 997-1021.
- 9. Barelli A, Soave PM, Del Vicario M, Barelli R. New experimental oximes in the management of organophosphorus pesticides poisoning. Minerva Anestesiol 2011;77:1197-203. PMID: 21799476
- 10. Masson P. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett 2011;206:5-13. doi: 10.1016/j.toxlet.2011.04.006
- 11. Kuča K, Bielavský J, Cabal J, Bielavská M. Synthesis of a potential reactivator of acetylcholinesterase 1-(4- hydroxyiminomethylpyridinium)-3 -(carbamoylpyridinium)- propane dibromide. Tetrahedron Lett 2003;44:3123-5. doi: 10.1016/S0040-4039(03)00538-0
- 12. Kuča K, Bielavský J, Cabal J, Kassa J. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2003;13:3545-7. doi: 10.1016/S0960-894X(03)00751-0
- 13. Musilek K, Holas O, Kuča K, Jun D, Dohnal V, Doležal M. Synthesis of asymmetrical bispyridinium compounds bearing cyano moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2006;16:5673-6. doi: 10.1016/j. bmcl.2006.08.011
- 14. Musilek K, Kuča K, Jun D, Dohnal V, Doležal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg. Med Chem Lett 2006;16:622-7. doi: 10.1016/j. bmcl.2005.10.059
- 15. Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuča K. Design of a potent reactivator of tabun-inhibited acetylcholinesterase-synthesis and evaluation of (E)-1- (4 -carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridi nium)-but-2-ene dibromide (K203). J Med Chem 2007;50:5514-8. doi: 10.1021/jm070653r
- 16. Kuča K, Stodulka P, Hrabinova M, Hanusova P, Jun D, Doležal B. Convenient preparation of the oxime HI-6 (dichloride and DMS) - antidote against nerve agents. Def Sci J 2008;58:399-404.
- 17. Thompson WR. Use of moving averages and interpolation to estimate median effective dose. Bacteriol Rev 1947;11:115-45. PMCID: PMC440915
- 18. Weil CS. Tables for convenient calculation of medianeffective dose (LD50 or ED50) and instruction in their use. Biometrics 1952;8:249-63.
- 19. Čalić M, Lucić Vrdoljak A, Radić B, Jelić D, Jun D, Kuča K, Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: Mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006;219:85-96. doi: 10.1016/j.tox.2005.11.003
- 20. Berend S, Lucić Vrdoljak A, Radić B, Kuča K. New bispyridinium oximes: In vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning. Chem Biol Interact 2008;175:413-6. doi: 10.1016/j.cbi.2008.04.031
- 21. Kovarik Z, Lucić Vrdoljak A, Berend S, Katalinić M, Kuča K, Musilek K, Radić B. Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 2009;60:19-26. doi: 10.2478/10004-1254-60-2009-1890
- 22. Park NJ, Jung YS, Musilek K, Jun D, Kuča K. Potency of several structurally different acetylcholinesterase reactivators to reactivate house fly and bovine acetylcholinesterases inhibited by paraoxon and DFP. Bull Korean Chem Soc 2006;27:1401-4.
- 23. Petroianu GA, Arafat K, Kuča K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. J Appl Toxicol 2006;26:64-71. doi: 10.1002/jat.1108
- 24. Petroianu GA, Nurulain SM, Nagelkerke N, Al-Sultan MA, Kuča K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J Appl Toxicol 2006;26:262-8. doi: 10.1002/jat.1143
- 25. Petroianu GA, Kalasz H. Comparison of the ability of pyridinium aldoximes to reactivate human RBC cholinesterases inhibited by ethyl- and methyl-paraoxon. Curr Org Chem 2007;11:1624-34. doi: 10.2174/ 138527212800564277
- 26. Lorke DE, Hasan MY, Arafat K, Kuča K, Musilek K, Schmitt A, Petroianu GA. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibitied by diisopropylfluorophosphate (DFP). J Appl Toxicol 2008;28:422-9. doi: 10.1002/jat.1344
- 27. Musilova L, Kuča K, Jung YS, Jun D. In vitro oxime assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase. Clin Toxicol 2009;47:545-50. doi: 10.1080/15563650903058914
- 28. Kuča K, Musilek K, Jun D, Pohanka M, Kumar Ghosh K, Hrabinova M. Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticideinhibited acetylcholinesterase. J Enzyme Inhib Med Chem 2010;25:509-12. doi: 10.3109/14756360903357569
- 29. Gupta B, Sharma R, Singh N, Kuča K, Acharya JR, Ghosh KK. In vitro reactivation kinetics of paraoxon- and DFPinhibited electric eel AChE using mono- and bis-pyridinium oximes. Arch Toxicol 2014;88:381-90. doi: 10.1007/s00204-013-1136-z
- 30. Yousefpour M, Bahrami F, Behboodi BS, Khoshbaten A, Asgari A. Paraoxon-induced ultrastructural growth changes of rat cultured hippocampal cells in neurobasal/B27. Toxicology 2006;217:221-7. doi:10.1016/j.tox.2005.09.018
- 31. Kovarik Z, Čalić M, Bosak A, Šinko G, Jelić D. In vitro evaluation of aldoxime interactions with human acetylcholinesterase. Croat Chem Acta 2008;81:47-57.
- 32. Petroianu GA, Lorke DE. Pyridinium oxime reactivators of cholinesterase inhibited by diisopropylfluorophosphate (DFP): Predictive value of in vitro testing for in vivo efficacy. Mini Rev Med Chem 2008;8:1328-42. doi: 10.2174/ 138955708786369555
- 33. Bhattacharjee AK, Kuča K, Musilek K, Gordon RK. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties. Chem Res Toxicol 2010;23:26-36. doi: 10.1021/tx900192u
- 34. Dawson RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994;14:317-31. doi: 10.1002/jat.2550140502